FULCRUM
Live / Registered — Registered (as of 28 Mar 2023)
What this means for you
Registered since 28 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88430181
- Registration number
- 7012695
- Mark type
- Stylized text
- Filed
- 14 May 2019
- Published for opposition
- 19 Nov 2019
- Registered
- 28 Mar 2023
- Attorney of record
- Joshua S. Jarvis
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of neuromuscular, hematological, rare and genetically defined diseases and disorders
Owner
- Fulcrum Therapeutics, Inc., Cambridge, MA, US
- Fulcrum Therapeutics, Inc., Cambridge, MA, US
- Fulcrum Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 05 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 02 Feb 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 02 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 23 Feb 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Feb 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Feb 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Jan 2023 — USE AMENDMENT FILED